Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

  • Giuseppina Rosaria Rita Ricciardi,
  • Barbara Adamo,
  • Antonio Ieni,
  • Luana Licata,
  • Roberta Cardia,
  • Giuseppa Ferraro,
  • Tindara Franchina,
  • Giovanni Tuccari,
  • Vincenzo Adamo

Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

  • Giuseppina Rosaria Rita Ricciardi, 
  • Barbara Adamo, 
  • Antonio Ieni, 
  • Luana Licata, 
  • Roberta Cardia, 
  • Giuseppa Ferraro, 
  • Tindara Franchina, 
  • Giovanni Tuccari, 
  • Vincenzo Adamo
PLOS
x

There are a number of errors in the caption of Fig 1. Please see the complete, correct Fig 1 caption here.

thumbnail
Fig 1. The E-cadherin, Ki-67 and AR expression in 45 patients TNBC.

Legend: [A, B] E-cadherin negative/positive staining; [C,D] Ki-67 level < or ≥ 20%; [E,F] negative/positive AR staining.

https://doi.org/10.1371/journal.pone.0132647.g001

Reference

  1. 1. Ricciardi GRR, Adamo B, Ieni A, Licata L, Cardia R, Ferraro G, et al. (2015) Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. PLoS ONE 10(6): e0128368. pmid:26039245